Candesartan could ameliorate the COVID-19 cytokine storm

BACKGROUND: Angiotensin receptor blockers (ARBs) reducing inflammation and protecting lung and brain function, could be of therapeutic efficacy in COVID-19 patients. METHODS: Using GSEA, we compared our previous transcriptome analysis of neurons injured by glutamate and treated with the ARB Candesar...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkahloun, Abdel G., Saavedra, Juan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439834/
https://www.ncbi.nlm.nih.gov/pubmed/32942152
http://dx.doi.org/10.1016/j.biopha.2020.110653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439834/
https://www.ncbi.nlm.nih.gov/pubmed/32942152
http://dx.doi.org/10.1016/j.biopha.2020.110653

Ejemplares similares